| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-ets | 36 | 2014 | 79 | 3.000 |
Why?
|
| Transcription Factors | 39 | 2015 | 753 | 3.000 |
Why?
|
| Proto-Oncogene Proteins | 44 | 2008 | 411 | 2.920 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 26 | 2014 | 106 | 2.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2014 | 756 | 1.880 |
Why?
|
| Trans-Activators | 18 | 2005 | 237 | 1.430 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 22 | 2013 | 65 | 1.430 |
Why?
|
| Cell Movement | 16 | 2014 | 630 | 1.220 |
Why?
|
| DNA-Binding Proteins | 20 | 2005 | 700 | 1.170 |
Why?
|
| Neoplasms | 8 | 2017 | 1667 | 0.960 |
Why?
|
| Multigene Family | 11 | 2013 | 93 | 0.940 |
Why?
|
| Breast Neoplasms | 8 | 2016 | 1536 | 0.900 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2011 | 138 | 0.880 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2015 | 268 | 0.830 |
Why?
|
| Nuclear Proteins | 10 | 2011 | 271 | 0.820 |
Why?
|
| Prostatic Neoplasms | 7 | 2011 | 778 | 0.810 |
Why?
|
| Cell Line, Tumor | 20 | 2015 | 1851 | 0.770 |
Why?
|
| Gene Expression Regulation | 20 | 2012 | 1293 | 0.770 |
Why?
|
| RNA, Messenger | 15 | 2013 | 1664 | 0.730 |
Why?
|
| MicroRNAs | 5 | 2014 | 447 | 0.730 |
Why?
|
| Transcription, Genetic | 17 | 2014 | 562 | 0.680 |
Why?
|
| Oncogenes | 11 | 2008 | 71 | 0.680 |
Why?
|
| Animals | 75 | 2016 | 20881 | 0.660 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2008 | 61 | 0.650 |
Why?
|
| Base Sequence | 34 | 2012 | 1015 | 0.640 |
Why?
|
| Cell Differentiation | 9 | 2015 | 1034 | 0.640 |
Why?
|
| Mice | 43 | 2015 | 8474 | 0.610 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2008 | 235 | 0.590 |
Why?
|
| Proto-Oncogenes | 13 | 1992 | 37 | 0.540 |
Why?
|
| Phenotype | 12 | 2016 | 947 | 0.500 |
Why?
|
| Antigens, Nuclear | 2 | 2005 | 24 | 0.490 |
Why?
|
| Humans | 79 | 2017 | 68618 | 0.490 |
Why?
|
| Neoplasm Invasiveness | 7 | 2012 | 369 | 0.490 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2014 | 135 | 0.480 |
Why?
|
| Protein Isoforms | 5 | 2011 | 246 | 0.470 |
Why?
|
| Mice, Transgenic | 11 | 2016 | 1033 | 0.470 |
Why?
|
| Autoantigens | 2 | 2005 | 91 | 0.470 |
Why?
|
| Receptors, Thromboxane | 3 | 2011 | 122 | 0.470 |
Why?
|
| Genetic Therapy | 5 | 2008 | 291 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 13 | 2014 | 615 | 0.460 |
Why?
|
| Cell Division | 12 | 2011 | 541 | 0.400 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2011 | 29 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2010 | 245 | 0.390 |
Why?
|
| Signal Transduction | 10 | 2015 | 2689 | 0.390 |
Why?
|
| DNA | 16 | 2012 | 597 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 710 | 0.380 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2011 | 116 | 0.380 |
Why?
|
| Transfection | 15 | 2014 | 782 | 0.370 |
Why?
|
| Thromboxane-A Synthase | 2 | 2011 | 24 | 0.370 |
Why?
|
| Rectal Neoplasms | 1 | 2011 | 75 | 0.360 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 282 | 0.360 |
Why?
|
| Hematologic Diseases | 1 | 2010 | 20 | 0.360 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 164 | 0.360 |
Why?
|
| Connective Tissue | 1 | 2010 | 61 | 0.350 |
Why?
|
| Megakaryocytes | 5 | 2010 | 18 | 0.340 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 122 | 0.340 |
Why?
|
| Neoplasm Proteins | 4 | 2006 | 307 | 0.340 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 63 | 0.330 |
Why?
|
| Retroviridae Proteins, Oncogenic | 6 | 1994 | 9 | 0.330 |
Why?
|
| Protein Biosynthesis | 3 | 2008 | 181 | 0.330 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 498 | 0.330 |
Why?
|
| Protein Binding | 9 | 2015 | 1027 | 0.320 |
Why?
|
| Lymphoid Tissue | 1 | 2008 | 30 | 0.320 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 371 | 0.310 |
Why?
|
| Avian Leukosis Virus | 5 | 1990 | 7 | 0.310 |
Why?
|
| Cell Proliferation | 7 | 2014 | 1174 | 0.310 |
Why?
|
| Colonic Neoplasms | 3 | 2009 | 299 | 0.310 |
Why?
|
| DNA Primers | 6 | 2010 | 302 | 0.310 |
Why?
|
| Models, Genetic | 5 | 2016 | 161 | 0.300 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 329 | 0.290 |
Why?
|
| Molecular Sequence Data | 26 | 2007 | 1447 | 0.280 |
Why?
|
| Cells, Cultured | 13 | 2013 | 2673 | 0.280 |
Why?
|
| Genes | 4 | 2000 | 86 | 0.280 |
Why?
|
| Chorioallantoic Membrane | 1 | 2006 | 3 | 0.280 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2006 | 13 | 0.270 |
Why?
|
| Genetic Markers | 2 | 2004 | 144 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 216 | 0.270 |
Why?
|
| Carrier Proteins | 6 | 2009 | 597 | 0.270 |
Why?
|
| RNA, Antisense | 5 | 2005 | 25 | 0.270 |
Why?
|
| Binding Sites | 14 | 2015 | 631 | 0.270 |
Why?
|
| Mice, Knockout | 11 | 2015 | 1692 | 0.270 |
Why?
|
| Homeostasis | 3 | 2014 | 291 | 0.260 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 114 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 2791 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 5 | 2011 | 332 | 0.260 |
Why?
|
| Repressor Proteins | 3 | 1998 | 183 | 0.250 |
Why?
|
| Thrombopoiesis | 1 | 2004 | 4 | 0.250 |
Why?
|
| Phosphoproteins | 2 | 2009 | 202 | 0.250 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 181 | 0.240 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 306 | 0.230 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 166 | 0.230 |
Why?
|
| Cell Lineage | 5 | 2015 | 146 | 0.230 |
Why?
|
| Genes, Viral | 7 | 2000 | 44 | 0.230 |
Why?
|
| Hematopoiesis | 2 | 2000 | 108 | 0.220 |
Why?
|
| Lymphopoiesis | 1 | 2003 | 16 | 0.220 |
Why?
|
| Cell Line | 10 | 2013 | 1752 | 0.220 |
Why?
|
| Chemokine CCL2 | 2 | 2014 | 101 | 0.220 |
Why?
|
| Disease Progression | 3 | 2013 | 1038 | 0.210 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2013 | 21 | 0.210 |
Why?
|
| Down-Regulation | 6 | 2012 | 447 | 0.210 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 597 | 0.210 |
Why?
|
| Chickens | 9 | 1990 | 232 | 0.200 |
Why?
|
| Fibroblasts | 7 | 2015 | 902 | 0.200 |
Why?
|
| Gene Expression | 9 | 2012 | 770 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2013 | 284 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 4 | 2005 | 511 | 0.200 |
Why?
|
| Heterozygote | 5 | 2012 | 174 | 0.200 |
Why?
|
| Cell Nucleus | 5 | 2012 | 305 | 0.190 |
Why?
|
| Cell Cycle | 5 | 2011 | 312 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2014 | 223 | 0.190 |
Why?
|
| Skin | 4 | 2010 | 451 | 0.180 |
Why?
|
| Adenocarcinoma | 5 | 2016 | 475 | 0.180 |
Why?
|
| Hemorrhage | 2 | 2014 | 328 | 0.180 |
Why?
|
| Fetal Death | 1 | 2000 | 49 | 0.180 |
Why?
|
| Endothelial Cells | 3 | 2015 | 384 | 0.170 |
Why?
|
| Amino Acid Sequence | 15 | 2003 | 1083 | 0.170 |
Why?
|
| Male | 19 | 2015 | 37321 | 0.160 |
Why?
|
| Female | 20 | 2016 | 38074 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 8 | 2013 | 852 | 0.160 |
Why?
|
| GATA1 Transcription Factor | 3 | 2010 | 19 | 0.160 |
Why?
|
| RNA-Binding Proteins | 5 | 2008 | 215 | 0.160 |
Why?
|
| Colorectal Neoplasms | 2 | 2014 | 561 | 0.160 |
Why?
|
| Snail Family Transcription Factors | 3 | 2014 | 31 | 0.150 |
Why?
|
| Spleen | 5 | 2013 | 301 | 0.150 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 40 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 322 | 0.150 |
Why?
|
| Proteomics | 2 | 2011 | 246 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 97 | 0.150 |
Why?
|
| Ribonucleoproteins | 1 | 1997 | 19 | 0.140 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 5 | 2004 | 49 | 0.140 |
Why?
|
| Cloning, Molecular | 9 | 2003 | 357 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2016 | 93 | 0.130 |
Why?
|
| Precipitin Tests | 4 | 2001 | 88 | 0.130 |
Why?
|
| Drosophila Proteins | 3 | 2004 | 44 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2015 | 2550 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 320 | 0.130 |
Why?
|
| Blood Cells | 1 | 2015 | 27 | 0.130 |
Why?
|
| Cell Transformation, Viral | 3 | 2000 | 26 | 0.120 |
Why?
|
| Transcriptional Activation | 6 | 2014 | 226 | 0.120 |
Why?
|
| Machine Learning | 1 | 2016 | 170 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2015 | 110 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 118 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 136 | 0.120 |
Why?
|
| Cadherins | 2 | 2013 | 93 | 0.120 |
Why?
|
| Collagen | 3 | 2008 | 636 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2012 | 629 | 0.120 |
Why?
|
| Models, Biological | 4 | 2008 | 981 | 0.120 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 94 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2014 | 130 | 0.120 |
Why?
|
| Molecular Chaperones | 3 | 2004 | 81 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 114 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 300 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 183 | 0.110 |
Why?
|
| Prognosis | 2 | 2011 | 2093 | 0.110 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 508 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2016 | 56 | 0.110 |
Why?
|
| Algorithms | 2 | 2016 | 1196 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 213 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2010 | 237 | 0.110 |
Why?
|
| Gene Silencing | 3 | 2012 | 137 | 0.110 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2013 | 35 | 0.110 |
Why?
|
| Software | 1 | 2016 | 418 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 18 | 0.110 |
Why?
|
| Scleroderma, Systemic | 2 | 2010 | 446 | 0.110 |
Why?
|
| Calcitriol | 1 | 2013 | 106 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 627 | 0.110 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2012 | 22 | 0.110 |
Why?
|
| Herpesvirus 8, Human | 1 | 2012 | 24 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 12 | 0.110 |
Why?
|
| Genetic Vectors | 8 | 2005 | 312 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 62 | 0.110 |
Why?
|
| Base Pair Mismatch | 2 | 2003 | 12 | 0.100 |
Why?
|
| Incidence | 1 | 2017 | 1603 | 0.100 |
Why?
|
| Actins | 3 | 2010 | 249 | 0.100 |
Why?
|
| Monocytes | 1 | 2013 | 210 | 0.100 |
Why?
|
| Lupus Nephritis | 2 | 2012 | 193 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 86 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 69 | 0.100 |
Why?
|
| Prevalence | 1 | 2017 | 1619 | 0.100 |
Why?
|
| Glomerulonephritis | 1 | 2012 | 77 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 328 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 434 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 2 | 2003 | 83 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2013 | 168 | 0.100 |
Why?
|
| DNA Repair Enzymes | 2 | 2003 | 53 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 7 | 2003 | 492 | 0.100 |
Why?
|
| Immunocompetence | 1 | 2011 | 19 | 0.100 |
Why?
|
| Adenoviridae | 4 | 2005 | 295 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 230 | 0.100 |
Why?
|
| Thymus Gland | 4 | 2007 | 97 | 0.100 |
Why?
|
| Thromboxane B2 | 1 | 2011 | 108 | 0.100 |
Why?
|
| Introns | 4 | 2016 | 68 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 201 | 0.100 |
Why?
|
| Immunoglobulin G | 3 | 2010 | 481 | 0.100 |
Why?
|
| DNA Repair | 2 | 2003 | 127 | 0.100 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2004 | 14 | 0.100 |
Why?
|
| Umbilical Veins | 2 | 2015 | 54 | 0.090 |
Why?
|
| Adipocytes | 2 | 2009 | 88 | 0.090 |
Why?
|
| Poly A | 1 | 1990 | 14 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 2 | 2000 | 74 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2010 | 24 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Platelet Count | 1 | 2010 | 100 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2008 | 238 | 0.090 |
Why?
|
| Homozygote | 1 | 2010 | 119 | 0.090 |
Why?
|
| Antibody Formation | 1 | 2010 | 93 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2010 | 434 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2004 | 214 | 0.090 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 37 | 0.090 |
Why?
|
| Drosophila | 3 | 2004 | 37 | 0.090 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2009 | 26 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2009 | 26 | 0.090 |
Why?
|
| Survival Rate | 3 | 2011 | 1056 | 0.090 |
Why?
|
| Immunophenotyping | 2 | 2015 | 110 | 0.090 |
Why?
|
| Macrophages | 1 | 2013 | 647 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 44 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2009 | 35 | 0.080 |
Why?
|
| Alpharetrovirus | 4 | 1988 | 4 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2010 | 94 | 0.080 |
Why?
|
| Bufanolides | 1 | 2009 | 1 | 0.080 |
Why?
|
| Uremia | 1 | 2009 | 10 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 12 | 0.080 |
Why?
|
| Procollagen | 1 | 2009 | 31 | 0.080 |
Why?
|
| Lymphocytes | 2 | 2007 | 228 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 124 | 0.080 |
Why?
|
| Mutation | 4 | 2014 | 1213 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 12 | 0.080 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2008 | 14 | 0.080 |
Why?
|
| Fibrillar Collagens | 1 | 2008 | 49 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 659 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2016 | 1173 | 0.080 |
Why?
|
| Viral Proteins | 2 | 1988 | 150 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2008 | 84 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2015 | 489 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2010 | 483 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 60 | 0.080 |
Why?
|
| Cattle | 3 | 2006 | 475 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 89 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2008 | 21 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 1990 | 95 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 261 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 1174 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 167 | 0.070 |
Why?
|
| Co-Repressor Proteins | 2 | 2004 | 8 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 28 | 0.070 |
Why?
|
| Integrin alpha2 | 2 | 2004 | 4 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 150 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 561 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 147 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2005 | 138 | 0.070 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2006 | 11 | 0.070 |
Why?
|
| DNA, Antisense | 1 | 2006 | 9 | 0.070 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 2 | 2004 | 9 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 32 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 40 | 0.070 |
Why?
|
| Mammals | 2 | 2000 | 47 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 60 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2015 | 954 | 0.070 |
Why?
|
| Chromosome Mapping | 7 | 1992 | 188 | 0.070 |
Why?
|
| Leukemia | 3 | 1992 | 117 | 0.070 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2006 | 74 | 0.070 |
Why?
|
| Bystander Effect | 1 | 2005 | 10 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2005 | 41 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2011 | 160 | 0.060 |
Why?
|
| G2 Phase | 1 | 2005 | 26 | 0.060 |
Why?
|
| Caspase 1 | 1 | 2005 | 22 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2006 | 379 | 0.060 |
Why?
|
| Pregnancy | 2 | 2010 | 2334 | 0.060 |
Why?
|
| NIH 3T3 Cells | 3 | 2014 | 65 | 0.060 |
Why?
|
| Ionomycin | 1 | 2005 | 24 | 0.060 |
Why?
|
| Cantharidin | 1 | 2005 | 5 | 0.060 |
Why?
|
| Jurkat Cells | 1 | 2005 | 59 | 0.060 |
Why?
|
| Apoptosis | 3 | 2010 | 1641 | 0.060 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2004 | 7 | 0.060 |
Why?
|
| Granulocytes | 1 | 2004 | 22 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2005 | 67 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2004 | 19 | 0.060 |
Why?
|
| Exons | 3 | 2016 | 122 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 2004 | 189 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2011 | 3187 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2008 | 89 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2004 | 66 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2004 | 137 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2004 | 133 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2003 | 742 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 282 | 0.060 |
Why?
|
| Macromolecular Substances | 2 | 2000 | 122 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 194 | 0.060 |
Why?
|
| Species Specificity | 3 | 1995 | 303 | 0.060 |
Why?
|
| Cell Communication | 1 | 2004 | 116 | 0.060 |
Why?
|
| Genes, Dominant | 2 | 2004 | 51 | 0.060 |
Why?
|
| COS Cells | 4 | 2006 | 155 | 0.060 |
Why?
|
| Histones | 2 | 1982 | 111 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 800 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 397 | 0.050 |
Why?
|
| Middle Aged | 4 | 2011 | 21147 | 0.050 |
Why?
|
| Chromatin | 2 | 2000 | 76 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2003 | 384 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 282 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4848 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2001 | 20 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 507 | 0.050 |
Why?
|
| Nucleosomes | 1 | 1982 | 25 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1982 | 27 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 370 | 0.050 |
Why?
|
| Endopeptidases | 1 | 1982 | 52 | 0.050 |
Why?
|
| Adult | 3 | 2011 | 21403 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 209 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Recombination, Genetic | 2 | 2000 | 62 | 0.050 |
Why?
|
| Risk Factors | 1 | 2011 | 5731 | 0.050 |
Why?
|
| Inflammation | 1 | 2007 | 1030 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2000 | 20 | 0.050 |
Why?
|
| Biological Evolution | 4 | 1992 | 86 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2000 | 61 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2000 | 32 | 0.050 |
Why?
|
| Dimerization | 1 | 2000 | 99 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 77 | 0.050 |
Why?
|
| RNA Splicing | 2 | 1991 | 32 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2003 | 431 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2000 | 75 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2000 | 58 | 0.050 |
Why?
|
| Child | 1 | 2011 | 6405 | 0.050 |
Why?
|
| Retroviridae Proteins | 3 | 1989 | 5 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 5717 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2013 | 324 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1996 | 63 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2000 | 107 | 0.040 |
Why?
|
| Forecasting | 1 | 2000 | 277 | 0.040 |
Why?
|
| Liver | 2 | 2006 | 1118 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 1991 | 80 | 0.040 |
Why?
|
| Agar | 1 | 1998 | 3 | 0.040 |
Why?
|
| Fibrosis | 3 | 2009 | 371 | 0.040 |
Why?
|
| Androgens | 1 | 1998 | 41 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 8912 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2000 | 432 | 0.040 |
Why?
|
| Down Syndrome | 2 | 1990 | 120 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 3 | 1988 | 49 | 0.040 |
Why?
|
| Collagen Type I | 2 | 2009 | 175 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 756 | 0.040 |
Why?
|
| Restriction Mapping | 4 | 1990 | 85 | 0.040 |
Why?
|
| Retroviridae | 3 | 1996 | 29 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2010 | 118 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2008 | 103 | 0.040 |
Why?
|
| Aged | 2 | 2011 | 14862 | 0.040 |
Why?
|
| HIV Long Terminal Repeat | 2 | 1996 | 8 | 0.040 |
Why?
|
| Proteinuria | 2 | 2010 | 136 | 0.040 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 1997 | 1 | 0.040 |
Why?
|
| RNA-Binding Protein EWS | 1 | 1997 | 5 | 0.040 |
Why?
|
| Proteins | 1 | 2000 | 474 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1996 | 15 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 1997 | 15 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1997 | 32 | 0.040 |
Why?
|
| Translocation, Genetic | 3 | 1992 | 74 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 86 | 0.040 |
Why?
|
| Cell Survival | 2 | 2014 | 901 | 0.030 |
Why?
|
| Kidney | 2 | 2012 | 945 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 2 | 2009 | 149 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2016 | 8 | 0.030 |
Why?
|
| RNA Editing | 1 | 2016 | 5 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 36 | 0.030 |
Why?
|
| Rabbits | 1 | 1997 | 509 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1995 | 10 | 0.030 |
Why?
|
| Time Factors | 4 | 2005 | 4655 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2015 | 1 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 9 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2015 | 30 | 0.030 |
Why?
|
| Genes, Reporter | 3 | 2005 | 191 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 99 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 100 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 52 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 68 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 167 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2014 | 42 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 2014 | 21 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 63 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 94 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 47 | 0.030 |
Why?
|
| Keratins | 1 | 1994 | 48 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 35 | 0.030 |
Why?
|
| Calcium Channel Agonists | 1 | 2013 | 18 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1993 | 38 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2014 | 159 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 47 | 0.030 |
Why?
|
| Brain | 2 | 2003 | 2176 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 207 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 49 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2014 | 100 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2013 | 64 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.030 |
Why?
|
| Xenopus | 2 | 1992 | 30 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1990 | 195 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1992 | 15 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2012 | 12 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1992 | 25 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1992 | 32 | 0.030 |
Why?
|
| Friend murine leukemia virus | 1 | 1992 | 10 | 0.030 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 2 | 2003 | 20 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2003 | 26 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2003 | 32 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2012 | 93 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2003 | 40 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 231 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2005 | 682 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 332 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2012 | 155 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 5300 | 0.030 |
Why?
|
| HIV-1 | 1 | 1993 | 177 | 0.030 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 166 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 77 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 83 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 95 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 76 | 0.020 |
Why?
|
| Pancreas | 1 | 2011 | 225 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2010 | 42 | 0.020 |
Why?
|
| Avian Leukosis | 1 | 1990 | 2 | 0.020 |
Why?
|
| Oncogene Proteins v-myb | 1 | 1990 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1990 | 8 | 0.020 |
Why?
|
| Invertebrates | 1 | 1990 | 8 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 10 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 248 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 77 | 0.020 |
Why?
|
| Permeability | 1 | 2010 | 131 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 13 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2010 | 171 | 0.020 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2009 | 7 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 24 | 0.020 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 37 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 29 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2009 | 6 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2009 | 15 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 63 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2009 | 49 | 0.020 |
Why?
|
| Bufo marinus | 1 | 2009 | 23 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 144 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 117 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 386 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 77 | 0.020 |
Why?
|
| Sea Urchins | 1 | 1988 | 6 | 0.020 |
Why?
|
| Leptin | 1 | 2009 | 80 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 617 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 242 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2009 | 95 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 57 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 714 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2009 | 103 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 173 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2009 | 284 | 0.020 |
Why?
|
| Pepsin A | 1 | 2007 | 8 | 0.020 |
Why?
|
| Decorin | 1 | 2007 | 8 | 0.020 |
Why?
|
| Castration | 1 | 2007 | 13 | 0.020 |
Why?
|
| Fibromodulin | 1 | 2007 | 3 | 0.020 |
Why?
|
| Lumican | 1 | 2007 | 8 | 0.020 |
Why?
|
| Keratan Sulfate | 1 | 2007 | 12 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1553 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2007 | 49 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2007 | 36 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 52 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 51 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 38 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 266 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1989 | 368 | 0.020 |
Why?
|
| Chromosome Deletion | 3 | 1991 | 41 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 144 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 362 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 142 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 38 | 0.020 |
Why?
|
| Diet | 1 | 2009 | 514 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 81 | 0.020 |
Why?
|
| fas Receptor | 1 | 2005 | 54 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 105 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 137 | 0.020 |
Why?
|
| Armadillo Domain Proteins | 1 | 2004 | 2 | 0.020 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2004 | 7 | 0.020 |
Why?
|
| Germ Cells | 1 | 2004 | 17 | 0.020 |
Why?
|
| Larva | 1 | 2004 | 39 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2004 | 22 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2005 | 294 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 42 | 0.020 |
Why?
|
| Chimera | 1 | 2004 | 33 | 0.020 |
Why?
|
| Androstadienes | 1 | 2004 | 41 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 64 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 1990 | 565 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 43 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2004 | 58 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 134 | 0.010 |
Why?
|
| Chemokines | 1 | 2004 | 119 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 217 | 0.010 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2003 | 17 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 1266 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 532 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 68 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 95 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 1204 | 0.010 |
Why?
|
| Myristic Acids | 1 | 2001 | 3 | 0.010 |
Why?
|
| Acetylation | 1 | 2002 | 94 | 0.010 |
Why?
|
| Gap Junctions | 1 | 2001 | 29 | 0.010 |
Why?
|
| Phosphorylation | 2 | 1996 | 1200 | 0.010 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2002 | 59 | 0.010 |
Why?
|
| MutL Proteins | 1 | 2001 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2001 | 78 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2001 | 254 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 267 | 0.010 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2001 | 36 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 258 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 250 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 626 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1991 | 67 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 866 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2000 | 10 | 0.010 |
Why?
|
| Pupa | 2 | 1991 | 2 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 525 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 791 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 92 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 95 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 376 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 54 | 0.010 |
Why?
|
| Transgenes | 1 | 1997 | 92 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 88 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 120 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1996 | 11 | 0.010 |
Why?
|
| G1 Phase | 1 | 1996 | 42 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1976 | 82 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1996 | 80 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 208 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 21 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 120 | 0.010 |
Why?
|
| Kinetics | 2 | 1994 | 1047 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1996 | 230 | 0.010 |
Why?
|
| Insecta | 1 | 1994 | 11 | 0.010 |
Why?
|
| Moths | 1 | 1993 | 14 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 272 | 0.010 |
Why?
|
| Point Mutation | 1 | 1994 | 97 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1994 | 107 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1994 | 112 | 0.010 |
Why?
|
| Tretinoin | 1 | 1994 | 92 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1994 | 69 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1994 | 162 | 0.010 |
Why?
|
| DNA, Superhelical | 1 | 1990 | 8 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1990 | 8 | 0.010 |
Why?
|
| RNA | 1 | 1991 | 171 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1990 | 9 | 0.010 |
Why?
|
| Mitogens | 1 | 1990 | 45 | 0.010 |
Why?
|
| Genome, Human | 1 | 1990 | 62 | 0.010 |
Why?
|
| Placenta | 1 | 1990 | 101 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 25 | 0.000 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 1986 | 1 | 0.000 |
Why?
|
| Trout | 1 | 1986 | 7 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1986 | 114 | 0.000 |
Why?
|
| Cats | 1 | 1986 | 292 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1986 | 90 | 0.000 |
Why?
|
| Codon | 1 | 1985 | 21 | 0.000 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1983 | 20 | 0.000 |
Why?
|
| Sulfates | 1 | 1976 | 28 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1976 | 134 | 0.000 |
Why?
|
| Urea | 1 | 1976 | 51 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1976 | 136 | 0.000 |
Why?
|
| Temperature | 1 | 1976 | 341 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1976 | 618 | 0.000 |
Why?
|